Expression of platelet derived growth factor and platelet derived growth factor receptor mRNA in a glioblastoma from a patient with Li-Fraumeni syndrome.

Abstract

Expression of platelet derived growth factor (PDGF) and PDGF-receptor mRNA was examined from a glioblastoma taken from a patient with Li-Fraumeni syndrome. Northern blot analysis and in situ hybridisation showed very high concentrations of both PDGF-A and PDGF alpha-receptor mRNA in the tumour. The overall pattern of PDGF expression was similar to those found in sporadic glioblastomas. Mutations in p53 has been implicated as an early pathogenic event leading to sporadic low grade astrocytomas, and is the third most common tumour type in patients with Li-Fraumeni syndrome, where they are predisposed due to a germline mutation in the p53 tumour suppressor gene. This study suggests that progression towards a glioblastoma in both the general population and in patients with Li-Fraumeni syndrome may involve potential autocrine and paracrine stimulation by growth factors such as PDGF.

• Authors: A Guha, D Glowacka, R Carroll, K Dashner, P M Black, C D Stiles
• Journal: Journal of neurology, neurosurgery, and psychiatry (J Neurol Neurosurg Psychiatry) Vol. 58 Issue 6 Pg. 711-4 (Jun 1995) ISSN: 0022-3050 [Print] England
• PMID: 7608673 (Publication Type: Case Reports, Journal Article)

Chemical References

• Platelet-Derived Growth Factor
• RNA, Messenger
• Receptors, Platelet-Derived Growth Factor

Topics

• Adult
• Blotting, Northern
• Brain Neoplasms (genetics)
• Gene Expression
• Glioblastoma (genetics)
• Humans
• In Situ Hybridization
• Li-Fraumeni Syndrome (genetics)
• Male
• Pedigree
• Platelet-Derived Growth Factor (genetics)
• RNA, Messenger (analysis)
• Receptors, Platelet-Derived Growth Factor (genetics)